ASO Author Reflections: The Value of Serum CEA for Prognostication at Staging and Response Evaluation in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9

Affiliations

• ¹ Amsterdam UMC, location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands. t.f.stoop@amsterdamUMC.nl.
• ² Cancer Center Amsterdam, Amsterdam, the Netherlands. t.f.stoop@amsterdamUMC.nl.
• ³ Division of Surgical Oncology, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. t.f.stoop@amsterdamUMC.nl.
• ⁴ Amsterdam UMC, location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands.
• ⁵ Cancer Center Amsterdam, Amsterdam, the Netherlands.
• ⁶ Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁷ Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁸ Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
• ⁹ Department of Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands.
• ¹⁰ Amsterdam UMC, location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands. m.g.besselink@amsterdamUMC.nl.
• ¹¹ Cancer Center Amsterdam, Amsterdam, the Netherlands. m.g.besselink@amsterdamUMC.nl.